Cost-effectiveness of immune checkpoint inhibitors in treating metastatic urothelial cancer

• Main Authors: Li-Yu Yang (Author), Jian-Ri Li (Author), Chuan-Shu Chen (Author), Chen-Li Cheng (Author), Sheng-Chun Hung (Author), Kun-Yuan Chiu (Author), Cheng-Kuang Yang (Author), Chiann-Yi Hsu (Author), Shian-Shiang Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: Immune checkpoint inhibitor (ICI) is an important treatment option for metastatic urothelial carcinoma (mUC) patients. A lot of clinical evidence proved the survival benefits of ICI, but cost-effectiveness of the treatment remains unclear. This study evaluates the cost-effectiveness of t...